Navigation Links
Rat Leptin Assay Kit from Immuno-Biological Laboratories, Inc.

ProductsRat Leptin Assay Kit from Immuno-Biological Laboratories, Inc.
Company Immuno-Biological Laboratories, Inc.
Item Rat Leptin Assay Kit
Price 
Description This kit #27295 has improved stability and convenience from the former kit #17295. However, the improved kit not only has overcome this problem but also produced some advantages as follows. At first, we have changed the formulation of HRP conjugated antibody from lyophilized product to liquid (0.4mL X 1). By this change, the stability of the conjugate has improved so that the conjugate can use for 12 months even in stored at 2-8C and use several times. And further, we have changed the formulation of TMB tablet (1mg X 2) to liquid (15mL X 1) with one bottle. By this change, the liquid TMB can use itself without preparation. And further, the stability of this liquid TMB has improved so that the liquid TMB can use for 12 months and use several times. Meantime, this change of formulation does not reflect change of performance. This meaning is that measurement value is not affected by this change in comparison with former kit The recessive obesity mutation, ob, identified in 1950, results in profound obesity and type II diabetes as part of a syndrome that resembles morbid obesity in humans. Freidmanfs group at Rockefeller University originally identified the obesity gene that encodes for Leptin in 1994. Leptin is a 16 KDa secreted protein produced by the ob gene. Adipose tissue produces Leptin and releases it into the bloodstream. As fat deposits grow, blood Leptin levels tends to increase. It has been suggested that Leptin acts as a lipostat, increasing as fat gets deposited into adipocytes. It is also found that the protein acts as a hormone instructing the brain to stop food consumption and to increase activity. The protein has also been shown to signal and probably control the onset of puberty. In addition, recent study shows Leptin acts as a potent inhibitor of bone formation through central nervous system.
Info Immuno-Biological Laboratories, Inc.Immuno-Biological Laboratories, Inc.
8201 Central Ave NE Suite P
Minneapolis, MN 55432

Call Immuno-Biological Laboratories, Inc. to buy products (US and Canada only; other locations use numbers below)
USA Canada 1-866-428-6857
Customer Service: 888-523-1246
Fax Number: 763-780-2988
Web Site: http://www.ibl-america.com/
NOTE: Price information is approximate list price and actual prices may vary.

Related biology products :

1. Porcine Leptin ELISA Kit from Diagnostic Systems Laboratories, Inc.
2. Rabbit Anti-Leptin Receptor Polyclonal Antibody, Unconjugated from BioVision
3. Rat Leptin from Cell Sciences
4. Rat Leptin, Unconjugated from R&D Systems
5. Rat Leptin from BioVision
6. Rat Leptin, Unconjugated from R&D Systems
7. Human Leptin Receptor, soluble (Ob sR) ELISA Kit from R&D Systems
8. Glutathione-S-Transferase (GST) Colorimetric Assay Kit from Sigma-Aldrich
9. In Vitro Osteogenesis Assay Kit from CHEMICON
10. Mast Cell Degranulation colorimetric Assay Kit from CHEMICON
11. PR Competitor Assay Green from Invitrogen
Request Info...
... the first all-inclusive collection of key procedures ... System. Methods developed by the leaders in ... protocols. This book will guide you from ... construction and analysis, to production of your ...
...
Antibodies were affinity purified using epitopes specific to USP33 immobilized on solid support....
Biology Products:
(Date:11/21/2014)... SAN JOSE, Calif. , Nov. 20, 2014 /PRNewswire/ ... a global leader in microcontroller (MCU) and touch technology ... digital temperature sensors with the widest V ... family delivers higher temperature accuracy and faster I 2 ... nonvolatile registers and serial EEPROM memory making them ideal ...
(Date:11/18/2014)... , Nov. 17, 2014 The Parenteral Drug Association ... regulatory agencies will speak and at least seven more will ... at the Omni Shoreham Hotel in Washington D.C. ... again to have significant support from the regulatory agencies in ... Europe in our effort to help advance the ...
(Date:11/12/2014)... Nov. 12, 2014 Crossmatch™, a leading provider ... U.are.U ® fingerprint readers have been deployed throughout ... Central Mexico . The bakery chain implemented ... payroll issues caused by employees clocking in for each ... fingerprint readers, Montparnasse relied on paper timecards and a ...
Breaking Biology News(10 mins):Atmel Launches Industry's First Wide-V(cc) Low-Power Temperature Sensor Family 2Atmel Launches Industry's First Wide-V(cc) Low-Power Temperature Sensor Family 3Atmel Launches Industry's First Wide-V(cc) Low-Power Temperature Sensor Family 4FDA's Janet Woodcock, EMA's Emer Cooke Headline PDA Quality Metrics Conference 2Montparnasse Pasteleria Achieves Time and Attendance Transparency with Crossmatch U.are.U Fingerprint Readers 2
... Medicine of the University of Southern California (USC) have ... hormone, activates genes in breast-cancer cells. Greater understanding of ... new treatments for the disease. Michael R. ... Department of Biochemistry and Molecular Biology, was the senior ...
... The Los Angeles World Airports (LAWA), which oversees airport ... contract modification to Unisys (NYSE: UIS ) to ... identify the 45,000 airport employees, contractors, police and others who ... is an early step in LAWA,s plan to move to ...
... environment and undermining many benefits we rely on from ... stability, according to a team of scientists writing in ... Issues in Ecology . In "Setting Limits: Using ... lead author Mark Fenn (USDA Forest Service) and nine ...
Cached Biology News:USC researchers discover key aspect of process that activates breast cancer genes 2Los Angeles World Airports Selects Unisys to Upgrade ID Card Reader System and Network 2Los Angeles World Airports Selects Unisys to Upgrade ID Card Reader System and Network 3Using air pollution thresholds to protect and restore ecosystem health 2Using air pollution thresholds to protect and restore ecosystem health 3
(Date:12/17/2014)... CA (PRWEB) December 17, 2014 ... today that it has entered into a technology ... Company (ADM) to apply DNA2.0’s proprietary protein engineering ... engineering process. , “We are extremely excited that ... engineering platform. This proprietary bioengineering technology has ...
(Date:12/17/2014)... Md. , Dec. 17, 2014 CASI ... company dedicated to the acquisition, development and commercialization of ... for the global market with a primary commercial focus ... it has been granted a Type C meeting with ... the meeting will be held in February 2015.  During ...
(Date:12/15/2014)... Israel , Dec. 15, 2014  BrainStorm ... leading developer of adult stem cell technologies for neurodegenerative ... Ltd. was awarded a grant of approximately $1.1 million ... Chief Scientist (OCS).  This is the eighth year that ... the Office of the Chief Scientist, which is part ...
(Date:12/15/2014)... COPENHAGEN, Denmark , Dec. 15, 2014 /PRNewswire/ ... its innovative TransCon technology to address significant unmet ... from its ongoing Phase 2 pediatric study to ... growth hormone deficiency, or GHD.  This interim analysis ... the anticipated total enrollment in the study, completing ...
Breaking Biology Technology:ADM and DNA2.0 Enter Into Protein Engineering Technology Access and Service Agreement 2CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 2CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 3CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 4CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 5BrainStorm Receives $1,100,000 for its 8th Annual Non-Dilutive Grant from Israel's Chief Scientist Office 2BrainStorm Receives $1,100,000 for its 8th Annual Non-Dilutive Grant from Israel's Chief Scientist Office 3Ascendis Pharma A/S Announces Positive Six-Month Interim Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 2Ascendis Pharma A/S Announces Positive Six-Month Interim Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 3Ascendis Pharma A/S Announces Positive Six-Month Interim Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 4